Malawi Medical Journal
College of Medicine, University of Malawi and Medical Association of Malawi
Vol. 21, No. 2, 2009, pp. 54-58
Bioline Code: mm09013
Full paper language: English
Document type: Research Article
Document available free of charge
Malawi Medical Journal, Vol. 21, No. 2, 2009, pp. 54-58
© Copyright 2009 - Malawi Medical Journal
Presentation of child sexual abuse cases to Queen Elizabeth Central Hospital following the establishment of an HIV post-exposure prophylaxis programme|
Chesshyre, Emily LD & Molyneux, Elizabeth M
To review the presentation and management of child sexual abuse cases presenting to Queen Elizabeth Central Hospital(QECH), Blantyre, since the introduction of an HIV postexposure prophylaxis programme.
Demographic and medical data was collected from all children presenting to Queen Elizabeth Central Hospital, Blantyre, Malawi between January 2005 and February 2007 with alleged child sexual abuse (CSA).
Between January 2005 and February 2007, 217 children presented with alleged CSA. This an average of 3 more per month since the previous year, a 57 percent increase. Physical examination showed signs of trauma 60% (130/217) of cases. 63% (137/217) of the cases presented within 72 hours of defilement. Overall in 42% (92/217) of children a one month course of HIV PEP was indicated and given. In 58% (125/217) HIV PEP was not indicated in view of normal examination, presentation too late (>72 hrs after abuse), multiple abuse episodes in the last 6 months, HIV test positive or HIV test refused. In 66% (144/217) of assessed children antibiotic treatment was given for the prevention and/ or treatment of sexually transmitted infections (STIs).
The introduction of an HIV PEP programme for victims of CSA has lead to increased numbers presenting and being treated. In conclusion it is likely that a significant number of children have been prevented from acquiring HIV and other STIs following CSA. The key area where our service needs
to be improved is in establishing documented follow up of all cases to monitor medication compliance, side effects and
rates of HIV seroconversion following CSA.
Alternative site location: http://revista.uft.edu.br/index.php/jbb/index